Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Malignancies × pamiparib × 1 year × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Advanced Malignant Solid Neoplasm 1 Advanced Malignancies 1

Interventions

Midazolam 2 Injections 2 zanidatamab 1 tislelizumab 1 sitravatinib 1 repaglinide 1 pamiparib 1 lenvatinib 1 drospirenone 1 cemiplimab 1 Temozolomide 1 Pemetrexed 1 Paclitaxel 1 Ipilimumab 1 HMPL-013 1 Gemcitabine 1 Ethinyl Estradiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04164199 2026-03-16

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

BeOne Medicines

Phase 3 Enrolling by invitation

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡